Research Article

Design and Characterization of Buccoadhesive Liquisolid System of an Antihypertensive Drug

Table 6

Postcompression evaluation of buccoadhesive tablets.

Parameter

Friability %0.3 ± 0.010.1 ± 0.010.2 ± 0.010.1 ± 0.010.1 ± 0.010.2 ± 0.010.1 ± 0.010.1 ± 0.010.1 ± 0.010.2 ± 0.01

Hardness (kg/cm2)8.0 ± 0.737.0 ± 0.257.0 ± 0.166.0 ± 0.357.0 ± 0.448.0 ± 0.177.0 ± 0.376.0 ± 0.458.0 ± 1.249.0 ± 0.68

Thickness (mm)3.87 ± 0.044.01 ± 0.054.02 ± 0.064.02 ± 0.094.01 ± 0.074.03 ± 0.084.06 ± 0.044.03 ± 0.054.01 ± 0.074.04 ± 0.04

Drug content (%)99.25 ± 2.21100.07 ± 2.798.76 ± 1.10110.2 ± 1.598.15 ± 2.1498.87 ± 2.1897.45 ± 2.2599.33 ± 2.18100.5 ± 1.1098.63 ± 2.21

Bioadhesive strength (g)30.0 ± 1.534.0 ± 1.639.0 ± 1.537.0 ± 1.338.0 ± 1.637.0 ± 0.735.0 ± 0.538.0 ± 1.436.0 ± 1.635.0 ± 1.5

Ex vivo residence time (h)4.0 ± 0.26.0 ± 0.47.0 ± 0.48.0 ± 0.38.0 ± 0.46.0 ± 0.27.0 ± 0.37.0 ± 0.38.0 ± 0.47.0 ± 0.3